Thomas J. McGarry

Thomas J. McGarry, MD, PhD, FHRS

Languages spoken: English

Academic Information

Departments Primary - Internal Medicine

Divisions: Cardiovascular Medicine

Academic Office Information

thomas.mcgarry@hsc.utah.edu

Board Certification

  • American Board of Internal Medicine (Internal Medicine)
  • American Board of Internal Medicine (Sub: Cardiovascular Disease)
  • American Board of Internal Medicine (Sub: Clinical Cardiac Electrophysiology)

Dr. Thomas McGarry specializes in Clinical Cardiac Electrophysiology. He has broad expertise in the ablation of ventricular tachycardia, as well as in the implantation and extraction of pacemakers and defibrillators. His special interests are complex ablations, atypical atrial flutter, recurrent arrhythmias after ablation, and inherited arrhythmia syndromes. Before joining the University of Utah he was on the faculty at Northwestern Memorial Hospital in Chicago. He is the author of over 30 publications and is a Fellow of the Heart Rhythm Society.

Education History

Fellowship University of California, San Diego
 Chief Fellow
University of California, San Diego
 Fellow
Postdoctoral Fellowship Harvard Medical School
 Postdoctoral Fellow
University of California, San Francisco
 Fellow
Residency Massachusetts General Hospital
 Resident
University of Chicago
 PhD
Professional Medical University of Chicago
 MD
University of Illinois
 BS
Undergraduate University of Illinois
 BS

Selected Publications

Journal Article

  1. Panopoulos AD, DAntonio M, Benaglio P, Williams R, Hashem SI, Schuldt BM, DeBoever C, Arias AD, Garcia M, Nelson BC, Harismendy O, Jakubosky DA, Donovan MKR, Greenwald WW, Farnam K, Cook M, Borja V, Miller CA, Grinstein JD, Drees F, Okubo J, Diffenderfer KE, Hishida Y, Modesto V, Dargitz CT, Feiring R, Zhao C, Aguirre A, McGarry TJ, Matsui H, Li H, Reyna J, Rao F, OConnor DT, Yeo GW, Evans SM, Chi NC, Jepsen K, Nariai N, Muller FJ, Goldstein LSB, Izpisua Belmonte JC, Adler E, Loring JF, Berggren WT, DAntonio-Chronowska A, Smith EN, Frazer KA (2017). iPSCORE: A Resource of 222 iPSC Lines Enabling Functional Characterization of Genetic Variation across a Variety of Cell Types. Stem Cell Reports, 8(4), 1086-1100.
  2. Panopoulos AD, DAntonio M, Benaglio P, Williams R, Hashem SI, Schuldt BM, DeBoever C, Arias AD, Garcia M, Nelson BC, Harismendy O, Jakubosky DA, Donovan MK, Greenwald WW, Farnam K, Cook M, Borja V, Miller CA, Grinstein JD, Drees F, Okubo J, Diffenderfer KE, Hishida Y, Modesto V, Dargitz CT, Feiring R, Zhao C, Aguirre A, McGarry TJ, Matsui H, Li H, Reyna J, Rao F, OConnor DT, Yeo GW, Evans SM, Chi NC, Jepsen K, Nariai N, Muller FJ, Goldstein LS, Izpisua Belmonte JC, Adler E, Loring JF, Berggren WT, DAntonio-Chronowska A, Smith EN, Frazer KA (2017). iPSCORE: A Resource of 222 iPSC Lines Enabling Functional Characterization of Genetic Variation across a Variety of Cell Types.LID - S2213-6711(17)30118-2 [pii]LID - 10.1016/j.stemcr.2017.03.012 [doi]. Stem Cell Reports.
  3. Salcedo JD, Pretorius VG, Hsu JC, Lalani GG, Schricker AA, Hebsur SM, McGARRY TJ, Hunter JA, Lewis KE, Krummen DE, Feld GK, Birgersdotter-Green U (2016). Compatibility of Radiofrequency Surgical Sponge Detection Technology with Cardiac Implantable Electronic Devices and Temporary Pacemakers. Pacing Clin Electrophysiol, 39(11), 1254-1260.
  4. Suchyta M, Miotto B, McGarry TJ (2015). An inactive geminin mutant that binds cdt1. Genes (Basel), 6(2), 252-66.
  5. McGarry TJ, Berman B, Birgersdotter-Green U, Pretorius V (2014). Right ventricular pseudoaneurysm after lead extraction. Heart Rhythm, 11(11), 2120-1.
  6. McGarry TJ, Joshi R, Kawata H, Patel J, Feld G, Birgersdotter-Green UM, Pretorius V (2014). Pocket infections of cardiac implantable electronic devices treated by negative pressure wound therapy. Europace, 16(3), 372-7.
  7. Kawata H, Patel J, McGarry T, Joshi R, Krummen D, Feld G, Birgersdotter- Green U (2014). Obese female patients have higher rates of lead dislodgement after ICD or CRT-D implantation. Int J Cardiol, 172(3), e522-524.
  8. Barry KA, Schultz KM, Payne CJ, McGarry TJ (2012). Geminin is required for mitotic proliferation of spermatogonia. Dev Biol, 371(1), 35-46.
  9. Kerns SL, Schultz KM, Barry KA, Thorne TM, McGarry TJ (2012). Geminin is required for zygotic gene expression at the Xenopus mid-blastula transition. PLoS One, 7(5), e38009.
  10. Schultz KM, Banisadr G, Lastra RO, McGuire T, Kessler JA, Miller RJ, McGarry TJ (2011). Geminin-deficient neural stem cells exhibit normal cell division and normal neurogenesis. PLoS One, 6(3), e17736.
  11. Shinnick KM, Eklund EA, McGarry TJ (2010). Geminin deletion from hematopoietic cells causes anemia and thrombocytosis in mice. J Clin Invest, 120(12), 4303-15.
  12. McGarry TJ, Bonaguidi M, Lyass L, Kessler JA, Bodily JM, Doglio L (2009). Enucleation of feeder cells and egg cells with psoralens. Dev Dyn, 238(10), 2614-21.
  13. Kim MK, McGarry TJ, O Broin P, Flatow JM, Golden AA, Licht JD (2009). An integrated genome screen identifies the Wnt signaling pathway as a major target of WT1. Proc Natl Acad Sci U S A, 106(27), 11154-9.
  14. Salabat MR, Melstrom LG, Strouch MJ, Ding XZ, Milam BM, Ujiki MB, Chen C, Pelling JC, Rao S, Grippo PJ, McGarry TJ, Bentrem DJ (2008). Geminin is overexpressed in human pancreatic cancer and downregulated by the bioflavanoid apigenin in pancreatic cancer cell lines. Mol Carcinog, 47(11), 835-44.
  15. Kerns SL, Torke SJ, Benjamin JM, McGarry TJ (2007). Geminin prevents rereplication during xenopus development. J Biol Chem, 282(8), 5514-21.
  16. McGarry TJ (2005). Measurement of geminin activity in Xenopus egg extracts. Methods Mol Biol, 296, 263-78.
  17. Benjamin JM, Torke SJ, Demeler B, McGarry TJ (2004). Geminin has dimerization, Cdt1-binding, and destruction domains that are required for biological activity. J Biol Chem, 279(44), 45957-68.
  18. McGarry TJ (2002). Geminin deficiency causes a Chk1-dependent G2 arrest in Xenopus. Mol Biol Cell, 13(10), 3662-71.
  19. Quinn LM, Herr A, McGarry TJ, Richardson H (2001). The Drosophila Geminin homolog: roles for Geminin in limiting DNA replication, in anaphase and in neurogenesis. Genes Dev, 15(20), 2741-54.
  20. Zou H, McGarry TJ, Bernal T, Kirschner MW (1999). Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis. Science, 285(5426), 418-22.
  21. McGarry TJ, Kirschner MW (1998). Geminin, an inhibitor of DNA replication, is degraded during mitosis. Cell, 93(6), 1043-53.
  22. McGarry TJ (1997). Small-pool screening. Trends Cell Biol, 7(9), 374.
  23. Kothakota S, Azuma T, Reinhard C, Klippel A, Tang J, Chu K, McGarry TJ, Kirschner MW, Koths K, Kwiatkowski DJ, Williams LT (1997). Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science, 278(5336), 294-8.
  24. King RW, Lustig KD, Stukenberg PT, McGarry TJ, Kirschner MW (1997). Expression cloning in the test tube. Science, 277(5328), 973-4.
  25. Stukenberg PT, Lustig KD, McGarry TJ, King RW, Kuang J, Kirschner MW (1997). Systematic identification of mitotic phosphoproteins. Curr Biol, 7(5), 338-48.
  26. Lustig KD, Stukenberg PT, McGarry TJ, King RW, Cryns VL, Mead PE, Zon LI, Yuan J, Kirschner MW (1997). Small pool expression screening: identification of genes involved in cell cycle control, apoptosis, and early development. Methods Enzymol, 283, 83-99.
  27. Solomon JM, Rossi JM, Golic K, McGarry T, Lindquist S (1991). Changes in hsp70 alter thermotolerance and heat shock regulation in Drosophila. New Biol, 3(11), 1106-20.
  28. Lindquist S, McGarry T (1986). Translational control of heat shock proteins in Drosophila. Cold Spring Harb Perspect Biol, 86-90.
  29. McGarry TJ, Lindquist S (1986). Inhibition of heat shock protein synthesis by heat-inducible antisense RNA. Proc Natl Acad Sci U S A, 83(2), 399-403.
  30. McGarry TJ, Lindquist S (1985). The preferential translation of Drosophila hsp70 mRNA requires sequences in the untranslated leader. Cell, 42(3), 903-11.
  31. Paulus TJ, McGarry TJ, Shekelle PG, Rosenzweig S, Switzer RL (1982). Coordinate synthesis of the enzymes of pyrimidine biosynthesis in Bacillus subtilis. J Bacteriol, 149(2), 775-8.

Book Chapter

  1. Gregory K Feld, Thomas McGarry, Nicholas Olsen, Gautam Lalani, and Amir Schricker (01/01/2015). Ablation of Cavotricuspid Isthmus-Dependent Atrial Flutters. In Shoei K. Stephen Huang and John M. Miller (Eds.), Catheter Ablation of Cardiac Arrhythmias (3rd, pp. 203-231). Philadelphia, PA: Elsevier/Saunders.
  2. Feld GK, McGarry T (2014). Atrial Flutter. In Levine GN, Debakey ME (Eds.), Levineʼs Color Atlas of Cardiovascular Disease (pp. 545-62). New Delhi, India: JayPee Brothers Medical Publishers,.

Case Report

  1. Matkowskyj KA, Wiseman WR, Robin JC, Norvell JP, Puthumana J, Nelson B, Peterson L, McGarry TJ, Tourtellotte WG (2010). Therapy-related myelodysplastic syndrome presenting as fulminant heart failure secondary to myeloid sarcoma. J Hematop, 3(1), 41-6.

Editorial

  1. McGarry TJ, Narayan SM (2014). Defining arrhythmic risk and defibrillator therapy in ARVC: shocking rhythm? J Am Coll Cardiol, 64(2), 126-8.
  2. McGarry TJ, Narayan SM (2014). What tissue does circumferential PV Isolation actually modulate? J Cardiovasc Electrophysiol, 25(2), 119-21.
  3. McGarry TJ, Narayan SM (2012). The anatomical basis of pulmonary vein reconnection after ablation for atrial fibrillation: wounds that never felt a scar? J Am Coll Cardiol, 59(10), 939-41.

Patent

  1. McGarry TJ (2012). Enucleation of Cells with Psoralens. U.S. Patent No. 20120052544 A1. Washington, D.C.:U.S. Patent and Trademark Office.
  2. McGarry TJ, Kroll KL, Kirschner MW (2003). Geminin Gene and Protein. U.S. Patent No. 6,548,290 B1. Washington, D.C.:U.S. Patent and Trademark Office.